Dr. Wedam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 Wisconsin Ave
Bldg 8, Rm 5101
Bethesda, MD 20889Phone+1 301-496-0901Fax+1 301-496-0047
Education & Training
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1997 - 2001
Georgetown University School of MedicineClass of 1997
Certifications & Licensure
VA State Medical License 1998 - 2026
DC State Medical License 1999 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer Start of enrollment: 2001 May 13
- Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer Start of enrollment: 2003 Nov 01
Publications & Presentations
PubMed
- 4 citationsMeasuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.Wanda Cui, Rodney P Rocconi, Ramya Thota, Richard A Anderson, Suanna S Bruinooge
The Lancet. Oncology. 2023-10-01 - 30 citationsU.S. FDA Drug Approvals for Breast Cancer - A Decade in Review.Shaily Arora, Preeti Narayan, Christy Osgood, Suparna Wedam, Tatiana M. Prowell
Clinical Cancer Research. 2021-10-28 - 4 citationsU.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review.Shaily Arora, Shaily Arora, Preeti Narayan, Preeti Narayan, Gwynn Ison
Clinical Cancer Research. 2021-10-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
